The prevalence of human liver cancer shows a broad spectrum of variation in distinct geographical regions, depending on different risk factors, and their pathogenesis is poorly understood. We study the significance of molecular alterations of K-ras gene in human liver carcinomas in a low-incidence region such as a Mediterranean area of Spain (Valencia and Gerona). Our results reveal a low incidence of K-ras codon 12 mutations in hepatocellular carcinomas (HCC) and a higher incidence in cholangiocarcinomas (CCC). Similar results have been obtained in high-risk areas. We conclude that K-ras gene mutations are not a major event in the malignant transformation of hepatic cells in this region of the Mediterranean but that molecular implications of hepatocellular and cholangiocarcinomas appear to be different.
1. Bishop JM. The molecular genetics of cancer. Science235:305-311, 1987
2.
2. Lowy D, Willumsen B. Function and regulation of rasAnnu Rev Biocem62:851-891, 1993
3.
3. Bos JL. ras oncogenes in human cancer: A review. Cancer Res49:4682-4689, 1989
4.
4. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell53:549-554, 1988
5.
5. Hayakumo T, Azuma T, Nakajima M, Yasuda K, Cho E, Mukai H, Muzuma Y, Ashihara T, Mizuno S, Hirano S, Ikeda EGK, Tokuda H, Takenaka A, Izumi H, Ikawa O, Aoike A, Kawai K. Prevalence of K-ras gene mutation in human colorectal cancers. Gastroenterol Jpn88:1539-1544, 1991
6.
6. Tsuda H, Hirohashi S, Shimosato Y, Ino Y, Yoshida T, Terada M. Low incidence of point mutation of c-Kiras oncogenes in human hepatocellular carcinoma. Jpn J Cancer Res80:196-199, 1989
7.
7. Sturm PDJ, Baas IO, Clement MJ, Nakeeb A, Offerhaus GJA, Hruban RH, Pitt HA. Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangicarcinomas from a high-incidence area. Int J Cancer78:695-698, 1998
8.
8. Tada M, Omata M, Ohto M. Analysis of ras gene mutations in human malignant tumors by polymerase chain reaction and direct sequencing. Cancer Res50:1121-1124, 1990
9.
9. Stork P, Loda M, Bosari S, Wiley B, Poppenhusen K, Wolfe H. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction. Oncogene. 6:857-862, 1991
10.
10. Challen C, Guo K, Collier JD, Cavanagh D, Bassendine MF. Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas. J Hepatol14:342-346, 1992
11.
11. Kang Y, Kim WH, Lee HW, Lee HK, Kim Y. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma. Lab Invest79:477-483, 1999
12.
12. Furubo S, Harada K, Shimonishi T, Katayanagi K, Tsui W, Nakanuma Y. Protein expression and genetic alterations of p53 and ras in intrahepatic cholangio-carcinoma. Histopathology35:230-240, 1999
13.
13. Verlaan-de Vries M, Bogaard ME, van den Elst H, van Boom JH, van der Eb AJ, Bos JL. A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. Gene50:313-320, 1986
14.
14. Kuper H, Tzonou A, Kaklamani E, Hsieh Ch, Lagiou P, Adami H, Trichopoulos D, Stuver S. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer85:498-502, 2000
15.
15. del Olmo JA, Serra MA, Rodriguez F, Escudero A, Gilabert F, Rodrigo JM. Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis. J Cancer Res Clin Oncol124:560-564, 1998
16.
16. Baba M, Yamamoto R, lishi H, Tatsuta M. Ha-ras mutations in N-nitrosomorpholine-induced lesions and inhibition of hepatocarcinogenesis by antisense sequences in rat liver. Int J Cancer72:815-820, 1997
17.
17. Boix-Ferrero J, Pellin A, Blesa R, Adrados M, Llombart-Bosch A. Absence of p53 gene mutations in hepatocarcinomas from a Mediterranean area of Spain. Virchows Arch434:497-501, 1999
18.
18. Watanabe M, Asaka M, Tanaka J, Kurosawa M, Kasai M, Miyazaki T. Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology107: 1147-1153, 1994
19.
19. Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S, Goseki N, Matsubara O, Takenaka K, Shichita M, Tanaka K, Shuda M, Yamamoto M. Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res59:4946-4990, 1999
